For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230921:nGNE7W0KdJ&default-theme=true
Albion Technology & General VCT PLC
LEI number: 213800TKJUY376H3KN16
As required by the UK Listing Authority's Disclosure Guidance and Transparency
Rule 4.2, Albion Technology & General VCT PLC today makes public its
information relating to the Half-yearly Financial Report (which is unaudited)
for the six months to 30 June 2023. This announcement was approved by the
Board of Directors on 21 September 2023.
The full Half-yearly Financial Report (which is unaudited) for the period to
30 June 2023, will shortly be sent to shareholders. Copies of the full
Half-yearly Financial Report will be shown via the Albion Capital Group LLP
website by clicking www.albion.capital/funds/AATG/30Jun23.pdf.
Investment objective and policy
The Company’s investment objective is to provide investors with a regular
and predictable source of dividend income, combined with the prospect of
long-term capital growth, through a balanced portfolio of predominantly
unquoted growth and technology businesses in a qualifying Venture Capital
Trust (“VCT”).
Investment policy
The Company will invest in a broad portfolio of unquoted growth and technology
businesses. Allocation of assets will be determined by the investment
opportunities which become available, but efforts will be made to ensure that
the portfolio is diversified in terms of sectors and stages of maturity of
portfolio companies.
VCT qualifying and non-qualifying investments
Application of the investment policy is designed to ensure that the Company
continues to qualify and is approved as a VCT by HM Revenue and Customs
(“VCT regulations”). The maximum amount invested in any one company is
limited to HMRC annual investment limits. It is intended that normally at
least 80% of the Company's funds will be invested in VCT qualifying
investments. The VCT regulations also have an impact on the type of
investments and qualifying sectors in which the Company can make an
investment.
Funds held either prior to investing in VCT qualifying assets or for liquidity
purposes will be held as cash on deposit, invested in floating rate notes or
similar instruments with banks or other financial institutions with high
credit ratings or invested in liquid open-ended equity funds providing income
and capital equity exposure (where it is considered economic to do so).
Investment in such open-ended equity funds will not exceed 7.5% of the
Company’s assets at the time of investment.
Risk diversification and maximum exposures
Risk is spread by investing in a number of different businesses within VCT
qualifying industry sectors using a mixture of securities. The maximum the
Company will invest in a single company is 15% of the Company’s assets at
cost at the time of investment. The value of an individual investment is
expected to increase over time as a result of trading progress and a
continuous assessment is made of investments' suitability for sale. It is
possible that individual holdings may grow in value to a point where they
represent a significantly higher proportion of total assets prior to a
realisation opportunity being available.
Borrowing powers
The Company’s maximum exposure in relation to gearing is restricted to 10%
of the adjusted share capital and reserves. The Directors do not have any
intention of utilising long-term gearing.
Financial calendar
Record date for second dividend for the year Payment date for second dividend for the year Financial year end 8 December 2023 29 December 2023 31 December
Financial summary
Unaudited six months ended 30 June 20 2 3 (pence per share) Unaudited six months ended 30 June 2022 (pence per share) Audited year ended 31 December 2022 (pence per share)
Opening net asset value 72.92 80.65 80.65
Capital return/(loss) 4.59 (0.10) (4.51)
Revenue return 0.1 5 0.11 0. 46
Total return/(loss) 4.74 0.01 (4.05)
Dividends paid ( 1.82 ) (2.02) (3.99)
Impact of share capital movements 0.18 0.05 0.3 1
Net asset value 76.02 78.69 72.92
Total shareholder value Ordinary shares (pence per share)
Total dividends paid since inception 125.44
Net asset value as at 30 June 2023 76.02
Total shareholder value to 30 June 202 3 201.46
In addition to the dividends paid above, the Board declared a second dividend
for the year ending 31 December 2023 of 1.90 pence per Ordinary share to be
paid on 29 December 2023 to shareholders on the register on 8 December 2023.
Further details regarding the total shareholder value for the historic C
Shares, Albion Income and Growth VCT PLC and Ordinary shares, as well as the
dividend record from inception of the Company in 2000, can be found at
www.albion.capital/funds/AATG under the ‘Financial Summary for Previous
Funds’ section.
Interim management report
Introduction
I am pleased to report a strong positive total return for the six months ended
30 June 2023 of 4.74 pence per share which represents a 6.5% return on opening
net asset value. We continue to see resilience and revenue growth from many of
our portfolio companies despite the difficult macroeconomic and geopolitical
backdrop, including continuing high inflation, rising interest rates and
volatility of quoted technology company valuations.
Results and dividends
The net asset value per Ordinary share as at 30 June 2023 has increased by
4.3% to 76.02 pence over the six months (30 June 2022: 78.69 pence; 31
December 2022: 72.92 pence) mainly due to the valuation uplift in Quantexa,
discussed below.
In line with our dividend policy, targeting around 5% of NAV per annum, the
Company paid a dividend of 1.82 pence per share during the period to 30 June
2023 (30 June 2022: 2.02 pence per share). The Company will pay a second
dividend for the financial year ending 31 December 2023 of 1.90 pence per
share on 29 December 2023 to shareholders on the register on 8 December 2023,
being 2.5% of the latest reported NAV at 30 June 2023.
This will bring the total dividends paid for the year ending 31 December 2023
to 3.72 pence per share, which equates to a 5.1% yield on the opening NAV of
72.92 pence per share at 31 December 2022.
Performance and portfolio update
The total gain on investments for the period ended 30 June 2023 was £9.4
million (six months ended 30 June 2022: gain of £1.6 million; year ended 31
December 2022: loss of £4.5 million). The key movement in the period was an
£11.4 million valuation uplift to the Quantexa holding following an
externally led $129 million Series E fundraising which completed in April
2023. The latest funding round made the company the first UK “Unicorn” of
2023 (a private company valuation over $1 billion) and the Board remain
excited about its prospects. Other gains in the period, which were driven by
revenue growth, included unrealised gains in Radnor House School of £0.8
million and Ophelos of £0.4 million.
These gains were offset by write downs in Black Swan Data which decreased by
£2.2 million, Locum’s Nest by £0.4 million and Speechmatics by £0.4
million.
The Company realised disposal proceeds of £1.0 million, the largest disposals
being Zift (£0.5 million) and a part disposal of our shareholding in our
quoted investment, Arecor Therapeutics PLC (£0.2 million). Further details of
other realisations during the period can be found in the realisations table
below.
During the period, a total of £0.4 million was deployed as follow-on
investments into the existing portfolio, including £0.3 million into Proveca
and £0.1 million into Seldon Technologies. The economic uncertainty, high
inflation rates and rising interest rates have resulted in a quiet period of
investment in the first half of 2023. However, there is a growing pipeline of
new investments, and investment activity has started to increase after the
period end, with £1.8 million invested at the date of this report into new
and follow-on investments since 30 June 2023.
Our top 3 portfolio companies now account for 29.2% of the Company’s NAV (30
June 2022: 21.6%; 31 December 2022: 22.2%). Further details of the portfolio
of investments can be found below.
Current portfolio sector allocation
Set out at the bottom of this announcement is the sector diversification of
the portfolio of investments as at 30 June 2023.
Board composition and succession planning
During the period Robin Archibald retired after nine years on the Board,
including two as Chairman and seven as Audit Committee Chairman. On behalf of
the Board and the Manager, I would like to thank and note my appreciation to
Robin for his invaluable contribution and wise guidance and leadership
throughout his time as a Director. As announced on 18 May 2023, Mary Anne
Cordeiro, having served a similar period, also retired during the period. The
Board and the Manager would like to thank her for her strong contribution. In
particular, her support and advice has been hugely appreciated. We wish both
Robin and Mary Anne well in their future endeavours.
As part of the Board’s succession planning, we were pleased to welcome David
Benda as a Director with effect from 26 June 2023, and Peter Moorhouse from 1
September 2023. David has extensive corporate banking experience working with
investment companies providing advice on fundraising, reorganisations and
restructurings. Peter brings a depth of corporate finance knowledge
particularly with companies in the healthcare and technology sectors, advising
primarily on equity financing, mergers and acquisitions.
The Nomination Committee continually monitors and reviews the membership of
the Board based on the spread of skills and contributions of its members, as
well as looking at succession planning requirements of the Company. The
Company has made several changes to the Board in recent years and continues to
review actively Board succession.
Share buy-backs
It remains the Board’s policy to buy-back shares in the market, subject to
the overall constraint that such purchases are in the Company’s interest.
This includes the maintenance of sufficient cash resources for investment in
new and existing portfolio companies and the continued payment of dividends to
shareholders.
It is the Board’s intention that such buy-backs should be at around a 5%
discount to NAV, in so far as market conditions and liquidity permit. The
Company purchased 2,117,126 Ordinary shares for treasury during the period at
a total cost of £1.6 million (30 June 2022: £1.2 million; 31 December 2022:
£2.5 million). The Company continues to conduct active buy-backs to help
provide good secondary market liquidity for those who want to dispose of all
or part of their shareholdings.
Risks and uncertainties
The Company faces a number of significant risks including rising interest
rates, high levels of inflation, the ongoing impact of geopolitical tensions,
and an expected period of economic stagnation in the UK and other markets. The
concentration risk to the technology sector is noted as technology company
valuations have become more uncertain in the current economic climate. The
Manager continually assesses the exposure to these risks for each portfolio
company and appropriate actions, where possible, are implemented.
In accordance with Disclosure Guidance and Transparency rules (“DTR”), the
Board confirms that the principal risks and uncertainties facing the Company
have not changed materially from those identified in the Annual Report and
Financial Statements for the year ended 31 December 2022. There is heightened
uncertainty, but this has not changed the nature of the principal risks. The
Board considers that the present processes for mitigating those risks remain
appropriate.
The principal risks faced by the Company are:
* Investment, performance and valuation risk;
* VCT approval risk;
* Cyber and data security risk;
* Reliance on key agents and personnel risk;
* Economic, political and social risk; and
* Discount risk.
A detailed analysis of the principal risks and uncertainties facing the
business can be found in the Annual Report and Financial Statements for the
year ended 31 December 2022 on pages 24 to 26, copies of which are available
on the Company’s webpage on the Manager’s website at
www.albion.capital/funds/AATG under the ‘Financial Reports and Circulars’
section.
Albion VCTs Prospectus Top Up Offers
The 2022/23 Offers were fully subscribed and closed having raised £15.5
million for the Company. The Board was pleased to see the high level of demand
for the Company’s shares from existing and new shareholders.
The proceeds of the Offers are being used to provide support to our existing
portfolio companies and to enable us to take advantage of new investment
opportunities as they arise. Details of the share allotments during the period
can be found in note 8.
Transactions with the Manager
Details of the transactions that took place with the Manager in the period can
be found in note 5. Details of related party transactions can be found in note
12.
Shareholder seminar
The Board is pleased to report that the Manager, Albion Capital, will host a
shareholder seminar this year on 15 November 2023 at the Royal College of
Surgeons. The Board considers this an important part of shareholder
communication as it provides an opportunity for shareholders to interact with
the Board and the Manager; shareholders are encouraged to attend. Places are
limited and to reserve a place please email info@albion.capital with subject
heading “Shareholder Seminar” and include your full name. You will receive
an email confirmation of your place, subject to availability.
Move to electronic communications
The Board wishes to minimise the environmental impact of how the Company
communicates with its shareholders. With this in mind, those shareholders that
continue to receive physical copies of the Annual Report and other
documentation, will receive a letter alongside this Half-yearly Financial
Report explaining the forthcoming move to electronic communications.
Outlook
Although there remain many uncertainties facing the Company, with the high
levels of inflation, elevated interest rates and geopolitical tensions, the
results for the period demonstrate the resilience of our portfolio during
these challenging times. Our strategy is to focus on dynamic sectors with long
term growth prospects such as technology and healthcare within which we
maintain a diversified portfolio in terms of companies at different stages of
maturity and across a variety of sub sectors. We remain confident that the
Company will continue to provide positive results to its shareholders over the
long-term.
Clive Richardson
Chairman
21 September 2023
Portfolio of investments
As at 30 June 20 2 3
Portfolio company % voting rights Cost £’000 Cumulative movement in value £’000 V alue £’000 Change in value for the period* £’000
Quantexa 2.4 2,740 25,601 28,341 11,408
Radnor House School (TopCo) 14.8 2,710 3,375 6,085 840
Proveca 7.2 1,438 3,648 5,086 103
Chonais River Hydro 15.7 2,169 2,161 4,330 296
Oviva 2.9 2,694 1,220 3,914 (388)
Cantab Research (T/A Speechmatics) 3.4 2,901 510 3,411 (407)
The Evewell Group 6.4 1,547 1,613 3,160 23
Egress Software Technologies 2.2 765 2,136 2,901 (57)
Runa Network 3.3 2,101 591 2,692 -
Gharagain River Hydro 18.5 1,526 1,003 2,529 214
Elliptic Enterprises 1.6 2,156 - 2,156 -
Convertr Media 6.9 1,105 1,017 2,122 (39)
Healios 2.5 1,500 416 1,916 -
MHS 1 22.5 1,565 93 1,658 -
Panaseer 3.1 1,122 532 1,654 (283)
TransFICC 2.7 1,275 377 1,652 -
Peppy Health 1.6 1,481 - 1,481 -
The Street by Street Solar Programme 8.1 895 563 1,458 (86)
Threadneedle Software Holdings (T/A Solidatus) 1.7 1,014 408 1,422 (208)
Toqio FinTech Holdings 2.0 1,400 - 1,400 -
InCrowd Sports 4.8 749 506 1,255 192
Regenerco Renewable Energy 7.9 822 382 1,204 (117)
Gravitee Topco (T/A Gravitee.io) 2.2 920 235 1,155 -
Beddlestead 9.8 1,200 (127) 1,073 (43)
Aridhia Informatics 4.9 950 73 1,023 (153)
PeakData 2.1 943 56 999 (15)
The Q Garden Company 33.4 934 65 999 -
Ophelos 1.9 492 412 904 411
GX Molecular (T/A CS Genetics) 2.9 846 - 846 -
Seldon Technologies 2.3 796 - 796 -
NuvoAir Holdings 1.4 564 231 795 (41)
Locum’s Nest 6.9 813 (70) 743 (439)
Alto Prodotto Wind 6.9 509 232 741 34
Cisiv 5.3 695 29 724 311
OutThink 2.7 687 - 687 -
PerchPeek 2.0 635 - 635 -
Diffblue 2.5 585 - 585 -
Premier Leisure (Suffolk) - 454 90 544 -
Accelex Technology 2.0 353 191 544 191
PetsApp 2.6 487 - 487 -
Erin Solar 15.7 440 12 452 -
DySIS Medical 2.6 2,589 (2,167) 422 30
5Mins AI 2.2 390 - 390 -
Imandra 1.6 215 101 316 (15)
AVESI 8.0 259 55 314 (33)
Brytlyt 1.9 406 (96) 310 (95)
Koru Kids 1.3 430 (121) 309 (52)
Ramp Software 1.9 277 - 277 -
Arecor Therapeutics PLC 0.4 149 124 273 (9)
Neurofenix 2.9 590 (334) 256 (334)
Tem-Energy 1.9 241 - 241 -
Harvest AD - 210 23 233 -
uMedeor (T/A uMed) 0.9 150 53 203 51
Mirada Medical 4.6 1,321 (1,125) 196 -
Regulatory Genome Development 0.8 118 40 158 40
Greenenerco 3.1 77 59 136 7
Infact Systems (T/A Infact) 1.9 96 - 96 -
Symetrica 0.2 91 (6) 85 11
Black Swan Data 8.3 4,714 (4,648) 66 (2,195)
uMotif 3.6 1,121 (1,120) 1 (119)
Limitless Technology 2.1 560 (560) - (282)
Elements Software - 19 (19) - -
Total fixed asset investments 63,001 37,8 4 0 100,841 8,752
T/A – trading as
* As adjusted for additions and disposals during the period.
Investment realisations in the period to 30 June 20 2 3 Cost £’000 Opening carrying value £’000 Disposal proceeds £’000 Total realised gain /(loss) £’000 G ain /(loss) on opening value £’000
Disposals:
Zift Channel Solutions 881 326 464 (417) 138
Arecor Therapeutics PLC 82 154 160 78 6
Oxsensis 3,484 95 109 (3,375) 14
Forward Clinical (T/A Pando) 196 - - (196) -
Loan stock repayments and other :
Alto Prodotto Wind 20 31 31 11 -
Greenenerco 4 5 5 1 -
Escrow adjustments and other* - - 209 209 209
Total 4,66 7 611 978 (3, 689 ) 367
* These comprise fair value movements on deferred consideration on previously
disposed investments and expenses which are incidental to the purchase or
disposal of an investment
£’000
Total change in value of investments for the year 8,752
Movement in loan stock accrued interest 35
Unrealised gains on fixed asset investments sub-total 8,787
Realised gains on fixed asset investments 367
Finance income from the unwinding of discount on deferred consideration 208
Total gains on investments as per Income statement 9,362
Responsibility statement
The Directors, Clive Richardson, Margaret Payn, David Benda, Peter Moorhouse
and Patrick Reeve, are responsible for preparing the Half-yearly Financial
Report. In preparing these condensed Financial Statements for the period to 30
June 2023 we, the Directors of the Company, confirm that, to the best of our
knowledge:
(a) the condensed set of Financial Statements, which has been prepared in
accordance with Financial Reporting Standard 104 “Interim Financial
Reporting”, gives a true and fair view of the assets, liabilities, financial
position and profit and loss of the Company as required by DTR 4.2.4R;
(b) the Interim management report includes a fair review of the information
required by DTR 4.2.7R (indication of important events during the first six
months and description of principal risks and uncertainties for the remaining
six months of the year); and
(c) the Interim management report includes a fair review of the information
required by DTR 4.2.8R (disclosure of related parties’ transactions and
changes therein).
This Half-yearly Financial Report has not been audited or reviewed by the
Auditor.
For and on behalf of the Board
Clive Richardson
Chairman
21 September 2023
Condensed income statement
Unaudited six months ended 30 June 2023 Unaudited six months ended 30 June 2022 Audited year ended 31 December 2022
Note Revenue Capital £’000 Total £’000 Revenue £’000 Capital £’000 Total £’000 Revenue £’000 Capital £’000 Total £’000
£’000
Gains/(losses) on investments 3 - 9,362 9,362 - 1,579 1,579 - (4,480) (4,480)
Investment income 4 713 - 713 619 - 619 1,631 - 1,631
Investment Manager’s fees* 5 ( 1 3 8 ) ( 1, 45 7 ) ( 1, 59 5 ) (129) (1,725) (1,854) (253) (2,541) (2,794)
Other expenses ( 32 1 ) - ( 32 1 ) (327) - (327) (658) - (658)
P rofit /(loss) on ordinary activities before tax 25 4 7,90 5 8,159 163 (146) 17 720 (7,021) (6,301)
Tax charge on ordinary activities - - - - - - - - -
P rofit /(loss) and total comprehensive income attributable to shareholders 25 4 7,90 5 8,159 163 (146) 17 720 (7,021) (6,301)
Basic and diluted return /(loss) per share (pence)* * 7 0.1 5 4.59 4.74 0.11 (0.10) 0.01 0.46 (4.51) (4.05)
* For more information on the allocation between revenue and capital please
see the accounting policies below
** adjusted for treasury shares
Comparative figures have been extracted from the unaudited Half-yearly
Financial Report for the six months ended 30 June 2022 and the audited
statutory accounts for the year ended 31 December 2022.
The accompanying notes form an integral part of this Half-yearly Financial
Report.
The total column of this Condensed income statement represents the profit and
loss account of the Company. The supplementary revenue and capital columns
have been prepared in accordance with The Association of Investment
Companies’ Statement of Recommended Practice.
Condensed balance sheet
Note Unaudited 30 June 20 2 3 £’000 Unaudited 30 June 2022 £’000 Audited 31 December 2022 £’000
Fixed asset investments 100,841 89,519 92,301
Current assets
Trade and other receivables 3, 4 19 3,221 3,456
Cash in bank and at hand 32,906 35,518 26,594
36,32 5 38,739 30,050
Payables: amounts falling due within one year Trade and other payables ( 1,751 ) (1,145) (832)
Net current assets 34,57 4 37,594 29,218
Total assets less current liabilities 135,415 127,113 121,519
Provisions falling due after one year ( 248 ) (562) (272)
Net assets 135,167 126,551 121,247
Equity attributable to equity holders
Called-up share capital 8 2,041 1,833 1,905
Share premium 15,958 76,358 5,534
Capital redemption reserve - 48 -
Unrealised capital reserve 37,67 1 28,229 24,828
Realised capital reserve 14,94 1 23,353 19,879
Other distributable reserve 64,556 (3,270) 69,101
Total equity shareholders’ funds 135,167 126,551 121,247
Basic and diluted net asset value per share (pence)* 7 6.02 78.69 72.92
* excluding treasury shares
Comparative figures have been extracted from the unaudited Half-yearly
Financial Report for the six months ended 30 June 2022 and the audited
statutory accounts for the year ended 31 December 2022.
The accompanying notes form an integral part of this Half-yearly Financial
Report.
These Financial Statements were approved by the Board of Directors and
authorised for issue on 21 September 2023 and were signed on its behalf by
Clive Richardson
Chairman
Company number: 04114310
Condensed statement of changes in equity
Called up share capital Share premium Capital redemption reserve Unrealised capit al reserve Realised capital reserve* Other distributable reserve* Total
£’000 £’000 £’000 £’000 £’000 £’000 £’000
As at 1 January 202 3 1,905 5,534 - 24,828 19,879 69,101 121,247
Profit/(loss) and total comprehensive income for the period - - - 8,787 (88 2 ) 25 4 8,159
Transfer of previously unrealised losses on disposal of investments - - - 4,05 6 (4,05 6 ) - -
Purchase of own shares for treasury - - - - - (1, 56 1 ) ( 1, 56 1 )
Issue of equity 136 10,700 - - - - 10,836
Cost of issue of equity - ( 276 ) - - - - ( 276 )
Dividends paid - - - - - ( 3,238 ) ( 3, 238 )
A s a t 30 June 20 2 3 2,041 15,958 - 37,67 1 14,94 1 64,556 135,167
As at 1 January 2022 1,536 52,687 48 33,469 18,259 995 106,994
Profit/(loss) and total comprehensive income for the period - - - (838) 692 163 17
Transfer of previously unrealised gains on disposal of investments - - - (4,402) 4,402 - -
Purchase of own shares for treasury - - - - - (1,188) (1,188)
Issue of equity 297 24,273 - - - - 24,570
Cost of issue of equity - (602) - - - - (602)
Dividends paid - - - - - (3,240) (3,240)
As at 30 June 2022 1,833 76,358 48 28,229 23,353 (3,270) 126,551
As at 1 January 2022 1,536 52,687 48 33,469 18,259 995 106,994
(Loss)/profit and total comprehensive income for the year - - - (6,498) (523) 720 (6,301)
Transfer of previously unrealised gains on disposal of investments - - - (2,143) 2,143 - -
Purchase of shares for treasury - - - - - (2,512) (2,512)
Issue of equity 369 29,943 - - - - 30,312
Cost of issue of equity - (739) - - - - (739)
Cancellation of share premium and capital redemption reserve - (76,357) (48) - - 76,405 -
Dividends paid - - - - - (6,507) (6,507)
As at 31 December 2022 1,905 5,534 - 24,828 19,879 69,101 121,247
*Included within these reserves are amounts of £28,406,000 (30 June 2022:
£17,686,000; 31 December 2022: £31,907,000) which are considered
distributable at 30 June 2023. Over the next three years an additional
£41,966,000 will become distributable. This is due to the HMRC requirement
that the Company cannot use capital raised in the past three years to make a
payment or distribution to shareholders.
Condensed statement of cash flows
Unaudited six months ended 30 June 20 2 3 £’000 Unaudited six months ended 30 June 2022 £’000 Audited year ended 31 December 2022 £’000
Cash flow from operating activities
Loan stock income received 484 767 1,199
Dividend income received - 80 132
Income from fixed term funds received 95 9 59
Deposit interest received 147 9 50
Investment management fee paid (1, 204 ) (1,196) (2,586)
Other cash payments (3 76 ) (302) (591)
Corporation tax paid - - -
Net cash flow generated from operating activities ( 854 ) (633) (1,737)
Cash flow from investing activities
Purchase of fixed asset investments ( 435 ) (6,308) (16,108)
Proceeds from disposals of fixed asset investments 1,257 8,337 9,530
Net cash flow generated from investing activities 822 2,029 (6,578)
Cash flow from financing activities
Issue of share capital 10,054 23,413 28,484
Cost of issue of equity - (18) (36)
Dividends paid* (2, 72 3 ) (2,671) (5,387)
Purchase of own shares (including costs) (9 87 ) (963) (2,513)
Net cash flow generated from financing activities 6,344 19,761 20,548
Increase in cash in bank and at hand 6,312 21,157 12,233
Cash in bank and at hand at start of period 26,594 14,361 14,361
Cash in bank and at hand at end of period 32,906 35,518 26,594
*The dividends paid shown in the cash flow are different to the dividends
disclosed in note 6 as a result of the non-cash effect of the Dividend
Reinvestment Scheme.
Notes to the condensed Financial Statements
1. Basis of preparation
The condensed Financial Statements have been prepared in accordance with
applicable United Kingdom law and accounting standards, including Financial
Reporting Standard 102 (“FRS 102”), and with the Statement of Recommended
Practice “Financial Statements of Investment Trust Companies and Venture
Capital Trusts” (“SORP”) issued by The Association of Investment
Companies (“AIC”). The Financial Statements have been prepared on a going
concern basis.
The preparation of the Financial Statements requires management to make
judgements and estimates that affect the application of policies and reported
amounts of assets, liabilities, income and expenses. The most critical
estimates and judgements relate to the determination of carrying value of
investments at fair value through profit and loss (“FVTPL”) in accordance
with FRS 102 sections 11 and 12. The Company values investments by following
the International Private Equity and Venture Capital Valuation (“IPEV”)
Guidelines as updated in 2022 and further detail on the valuation techniques
used are outlined in note 2 below.
Company information can be found on page 4 of the Half-yearly Financial
Report.
2. Accounting policies
Fixed investments
The Company’s business is investing in financial assets with a view to
profiting from their total return in the form of income and capital growth.
This portfolio of financial assets is managed, and its performance evaluated
on a fair value basis, in accordance with a documented investment policy, and
information about the portfolio is provided internally on that basis to the
Board.
In accordance with the requirements of FRS 102, those undertakings in which
the Company holds more than 20% of the equity as part of an investment
portfolio are not accounted for using the equity method. In these
circumstances the investment is measured at Fair Value Through Profit and Loss
(“FVTPL”).
Upon initial recognition (using trade date accounting) investments, including
loan stock, are classified by the Company as FVTPL and are included at their
initial fair value, which is cost (excluding expenses incidental to the
acquisition which are written off to the Income statement).
Subsequently, the investments are valued at ‘fair value’, which is
measured as follows:
* Investments listed on recognised exchanges are valued at their bid prices at
the end of the accounting period or otherwise at fair value based on published
price quotations.
* Unquoted investments, where there is no active market, are valued using an
appropriate valuation technique in accordance with the IPEV Guidelines.
Indicators of fair value are derived using established methodologies including
earnings multiples, revenue multiples, the level of third party offers
received, cost or prices of recent investment rounds, net assets and industry
valuation benchmarks. Where the price of recent investment is used as a
starting point for estimating fair value at subsequent measurement dates, this
has been benchmarked using an appropriate valuation technique permitted by the
IPEV guidelines.
* In situations where the cost or price of recent investment is used,
consideration is given to the circumstances of the portfolio company since
that date in determining fair value. This includes consideration of whether
there is any evidence of deterioration or strong definable evidence of an
increase in value. In the absence of these indicators, other valuation
techniques are employed to conclude on the fair value as of the measurement
date. Examples of events or changes that could indicate a diminution include:
* the performance and/or prospects of the underlying business are
significantly below the expectations on which the investment was based; or
* a significant adverse change either in the portfolio company’s business or
in the technological, market, economic, legal or regulatory environment in
which the business operates; or
* market conditions have deteriorated, which may be indicated by a fall in the
share prices of quoted businesses operating in the same or related sectors.
Investments are recognised as financial assets on legal completion of the
investment contract and are de-recognised on legal completion of the sale of
an investment.
Dividend income is not recognised as part of the fair value movement of an
investment but is recognised separately as investment income through the other
distributable reserve when a share becomes ex-dividend.
Current assets and payables
Receivables (including debtors due after more than one year), payables and
cash are carried at amortised cost, in accordance with FRS 102. Debtors due
after more than one year meet the definition of a financing transaction and
are held at amortised cost, and interest will be recognised through capital
over the credit period using the effective interest method. There are no
financial liabilities other than payables.
Provisions
Provisions relate to the performance incentive fee payable to the Manager. The
provision requires management to make judgements and estimates under the Basis
of Preparation. The performance incentive fee provision is the best estimate
of the probable amounts payable in respect of the five-year performance
measurement period for the performance incentive fee. The most significant
assumption when calculating this amount, is that of future performance. This
has been calculated by reference to the Company’s five year rolling historic
returns and has been corroborated by a portfolio return analysis using
appropriate benchmarks.
Investment income
Equity income
Dividend income is included in revenue when the investment is quoted
ex-dividend.
Unquoted loan stock and other preferred income
Fixed returns on non-equity shares and debt securities are recognised when the
Company’s right to receive payment and expected settlement is established.
Where interest is rolled up and/or payable at redemption then it is recognised
as income unless there is reasonable doubt as to its receipt.
Fixed term funds income
Funds income is recognised on an accruals basis using the agreed rate of
interest.
Bank deposit income
Interest income is recognised on an accruals basis using the rate of interest
agreed with the bank.
Investment management fee, performance incentive fee and expenses
All expenses have been accounted for on an accruals basis. Expenses are
charged through the other distributable reserve except the following which are
charged through the realised capital reserve:
* 90% of management fees and 100% of performance incentive fees, if any, are
allocated to the realised capital reserve.
* expenses which are incidental to the purchase or disposal of an investment
are charged through the realised capital reserve.
Taxation
Taxation is applied on a current basis in accordance with FRS 102. Current tax
is tax payable or refundable in respect of the taxable profit or tax loss for
the current period or past reporting periods using the tax rates and laws that
have been enacted or substantively enacted at the financial reporting date.
Taxation associated with capital expenses is applied in accordance with the
SORP.
Deferred tax is provided in full on all timing differences at the reporting
date. Timing differences are differences between taxable profits and total
comprehensive income as stated in the Financial Statements that arise from the
inclusion of income and expenses in tax assessments in periods different from
those in which they are recognised in the Financial Statements. As a VCT the
Company has an exemption from tax on capital gains. The Company intends to
continue meeting the conditions required to obtain approval as a VCT for the
foreseeable future. The Company, therefore, should have no material deferred
tax timing differences arising in respect of the revaluation or disposal of
investments and the Company has not provided for any deferred tax.
Share capital and reserves
Called-up share capital
This accounts for the nominal value of the shares.
Share premium
This accounts for the difference between the price paid for the Company’s
shares and the nominal value of those shares, less issue costs.
Capital redemption reserve
This reserve accounts for amounts by which the issued share capital is
diminished through the repurchase and cancellation of the Company’s own
shares.
Unrealised capital reserve
Increases and decreases in the valuation of investments held at the period end
against cost are included in this reserve.
Realised capital reserve
The following are disclosed in this reserve:
* gains and losses compared to cost on the realisation of investments, or
permanent diminutions in value (including gains recognised on the realisation
of investments where consideration is deferred that are not distributable as a
matter of law);
* finance income in respect of the unwinding of the discount on deferred
consideration that is not distributable as a matter of law;
* expenses, together with the related taxation effect, charged in accordance
with the above policies; and
* dividends paid to equity holders where paid out by capital.
Other distributable reserve
The special reserve, treasury share reserve and the revenue reserve were
combined in 2012 to form a single reserve named “other distributable
reserve”.
This reserve accounts for movements from the revenue column of the Income
statement, the payment of dividends, the buy-back of shares and other
non-capital realised movements.
Dividends
Dividends by the Company are accounted for in the period in which the
liability to make the payment has been established or approved at the Annual
General Meeting.
Segmental reporting
The Directors are of the opinion that the Company is engaged in a single
operating segment of business, being investment in smaller early stage
companies principally based in the UK.
3. Gains/(losses) on investments
Unaudited six months ended 30 June 20 2 3 £’000 Unaudited six months ended 30 June 2022 £’000 Audited year ended 31 December 2022 £’000
Unrealised gains/(losses) on fixed asset investments 8,787 (838) (6,498)
Realised gains on fixed asset investments 367 2,238 1,647
Unwinding of discount on deferred consideration 208 179 371
9,362 1,579 (4,480)
4. Investment income
Unaudited six months ended 30 June 20 2 3 £’000 Unaudited six months ended 30 June 2022 £’000 Audited year ended 31 December 2022 £’000
Loan stock interest 448 505 978
Bank deposit interest 147 9 50
Income from fixed term funds 95 9 59
Dividend income 23 96 544
713 619 1,631
5. Investment Manager’s fees
Unaudited six months ended 30 June 20 2 3 £’000 Unaudited six months ended 30 June 2022 £’000 Audited year ended 31 December 2022 £’000
Investment management fee charged to revenue 138 129 253
Investment management fee charged to capital 1, 240 1,163 2,269
Total investment management fee 1, 378 1,292 2,522
Movement in provision for performance incentive fee charged to capital 21 7 562 272
1, 59 5 1,854 2,794
Further details of the Management agreement under which the investment
management fee and performance incentive fee are paid are given in the
Strategic report on page 19 of the Annual Report and Financial Statements for
the year ended 31 December 2022.
During the period, services for a total value of £1,478,000 (30 June 2022:
£1,392,000; 31 December 2022: £2,722,000) were purchased by the Company from
Albion Capital Group LLP (“Albion Capital”) comprising £1,378,000 of
management fees (30 June 2022: £1,292,000; 31 December 2022: £2,522,000) and
£100,000 of administration fees (30 June 2022: £100,000; 31 December 2022:
£200,000). At the financial period end, the amount due to Albion Capital in
respect of these services disclosed as accruals was £822,000 (administration
fee accrual £50,000, management fee accrual £772,000) (30 June 2022:
£807,000; 31 December 2022: £647,000).
Currently a best estimate provision of £489,000 has been calculated and
included in relation to potential performance incentive fees which arise from
performance to 30 June 2023, which would become payable over the periods to 31
December 2027. Within this amount, £241,000 is included in payables falling
due within one year in relation to the first payment calculated on the
five-year period ending 31 December 2023, which is payable after the adoption
of the audited accounts at the 2024 AGM based on actual year end performance.
Further details can be found in note 9.
During the period, the Company was not charged by Albion Capital in respect of
Patrick Reeve’s services as a Director (30 June 2022 and 31 December 2022:
£nil).
Albion Capital, its partners and staff (including Patrick Reeve), held
1,636,367 Ordinary shares in the Company as at 30 June 2023.
Albion Capital is, from time to time, eligible to receive arrangement fees and
monitoring fees from portfolio companies. During the period to 30 June 2023,
fees of £81,000 attributable to the investments of the Company were received
by Albion Capital pursuant to these arrangements (30 June 2022: £132,000; 31
December 2022: £345,000).
6. Dividends Unaudited six months ended 30 June 20 2 3 £’000 Unaudited six months ended 30 June 2022 £’000 Audited year ended 31 December 2022 £’000
First dividend of 1.82p per share paid on 30 June 2023 (30 June 2022: 2.02p per share) 3,2 38 3,240 3,240
Second dividend of 1.97p per share paid on 30 December 2022 - - 3,267
3,2 38 3,240 6,507
The Directors have declared a dividend of 1.90 pence per Ordinary share (total
approximately £3,378,000) payable on 29 December 2023, to shareholders on the
register on 8 December 2023.
7. Basic and diluted return/(loss) per share
Unaudited six months ended 30 June 20 2 3 Unaudited six months ended 30 June 2022 Audited year ended 31 December 2022
Revenue Capital Revenue Capital Revenue Capital
Profit/(loss) attributable to equity shares (£’000) 25 4 7,90 5 163 (146) 721 (7,022)
Weighted average shares in issue (adjusted for treasury shares) 172,268,564 149,501,675 155,471,219
Return/(loss) attributable per equity share (pence) 0.1 5 4.59 0.11 (0.10) 0.46 (4.51)
The weighted average number of shares is calculated after adjusting for
treasury shares of 26,353,527 (30 June 2022: 22,449,076; 31 December 2022:
24,236,401).
There are no convertible instruments, derivatives or contingent share
agreements in issue, and therefore no dilution affecting the return/(loss) per
share. The basic return/(loss) per share is therefore the same as the diluted
return/(loss) per share.
8. Share capital
Allotted, called up and fully paid shares of 1 penny each Unaudited 30 June 202 3 Unaudited 30 June 2022 Audited 31 December 2022
Number of shares 204, 149,764 183,280,301 190,510,554
Nominal value of allotted shares (£’000) 2,04 1 1,833 1,905
Voting rights (number of shares net of treasury shares) 177,796,237 160,831,225 166,274,153
During the period to 30 June 2023 the Company purchased 2,117,126 Ordinary
shares (nominal value £21,171) for treasury at a cost of £1,561,000. The
total number of Ordinary shares held in treasury as at 30 June 2023 was
26,353,527 (30 June 2022: 22,449,076; 31 December 2022: 24,236,401)
representing 12.9% of the Ordinary shares in issue as at 30 June 2023.
Under the terms of the Dividend Reinvestment Scheme, the following new
Ordinary shares of nominal value 1 penny each were allotted during the period
to 30 June 2023:
Date of allotment Number of shares allotted Aggregate nominal value of shares (£’000) Issue price (pence per share) Net invested (£’000) Opening market price on allotment date (pence per share)
30 June 2023 685,420 7 76.77 506 73.00
Under the terms of the Albion VCTs Prospectus Top Up Offers 2022/23, the
following new Ordinary shares, of nominal value 1 penny each, were allotted
during the period to 30 June 2023:
Date of allotment Number of shares allotted Aggregate nominal value of shares (£’000) Issue price (pence per share) Net consideration received (£’000) Opening market price on allotment date (pence per share)
31 March 2023 12,395,704 124 79.60 9,621 74.00
14 April 2023 95,387 1 78.80 74 74.00
14 April 2023 31,564 - 79.20 24 74.00
14 April 2023 431,135 4 79.60 335 74.00
12,953,790 129 10,054
9. Provisions and significant estimates
In accordance with the AIC SORP and FRS102, a provision for a performance
incentive fee (“PIF") is required to be estimated and accounted for in the
financial statements. The PIF is calculated on a five-year rolling average
performance basis, with a 5% hurdle applied to the opening net asset value
each year, which is in line with our current dividend target. The first five
year performance period will take into account the audited results of the five
years ending 31 December 2023.
Any PIF will only be paid on actual year end audited results, and this
provision is the Board’s best estimate of the potential obligation relating
to the inclusion of realised performance from 1 January 2019 to 30 June 2023
in any future five-year rolling periods.
Movement in provision Unaudited six months ended 30 June 20 2 3 £’000 Unaudited six months ended 30 June 2022 £’000 Audited year ended 31 December 2022 £’000
Opening provision 272 - -
Movement in provision 217 562 272
Closing provision 489 562 272
Payable within one year: 241 - -
Payable in more than one year: 248 562 272
The most significant assumption when calculating this amount, is that of
future performance. Results for the period from 1 January 2019 to 30 June
2023 are included in the calculation; a forecast has been used for current
year performance and future years assume performance is achieved in line with
the five year historic rolling average. The provision included in the
financial statements has been calculated on this basis and has been
corroborated by a portfolio return analysis using appropriate benchmarks.
Performance fees are only paid on final audited results for a five year
period.
The average return per annum over each rolling five year period since the
Company’s inception in 2000 to the date of approval of the new performance
fee arrangements was 5.85%. This smooths the performance through the various
economic events and cycles seen since inception. This has resulted in a
provision of £489,000 at 30 June 2023.
10. Commitments and contingencies
As at 30 June 2023, the Company had no financial commitments in respect of
investments (30 June 2022 and 31 December 2022: £nil).
There are no contingencies or guarantees of the Company as at 30 June 2023 (30
June 2022 and 31 December 2022: £nil).
11. Post balance sheet events
There have been no material post balance sheet events since 30 June 2023.
12. Related party transactions
Other than transactions with the Manager as disclosed in note 5, there are no
other related party transactions requiring disclosure.
13. Going concern
The Board has conducted a detailed assessment of the Company’s ability to
meet its liabilities as they fall due. Cash flow forecasts are updated and
discussed quarterly at Board meetings and have been stress tested to allow for
the forecast impact of the current economic climate and increasingly volatile
geopolitical backdrop. The Board has revisited and updated its assessment of
liquidity risk and concluded that it remains unchanged since the last Annual
Report and Financial Statements. Further details can be found on page 91 of
those accounts.
The portfolio of investments is diversified in terms of sector and the major
cash outflows of the Company (namely investments, dividends and share
buy-backs) are within the Company’s control. Accordingly, after making
diligent enquiries, the Directors have a reasonable expectation that the
Company has adequate cash and liquid resources to continue in operational
existence for the foreseeable future. For this reason, the Directors have
adopted the going concern basis in preparing this Half-yearly Financial Report
and this is in accordance with the Guidance on Risk Management, Internal
Control and Related Financial and Business Reporting issued by the Financial
Reporting Council in September 2014, and the subsequent updated Going concern,
risk and viability guidance issued by the FRC in 2021.
14. Other information
The information set out in this Half-yearly Financial Report does not
constitute the Company’s statutory accounts within the terms of section 434
of the Companies Act 2006 for the periods ended 30 June 2023 and 30 June 2022
and is unaudited. The information for the year ended 31 December 2022 does not
constitute statutory accounts within the terms of section 434 of the Companies
Act 2006 and is derived from the statutory accounts for that financial year,
which have been delivered to the Registrar of Companies. The Auditor reported
on those accounts; their report was unqualified and did not contain a
statement under s498 (2) or (3) of the Companies Act 2006.
15. Publication
This Half-yearly Financial Report is being sent to shareholders and copies
will be made available to the public at the registered office of the Company,
Companies House, the National Storage Mechanism and also electronically at
www.albion.capital/funds/AATG, where the Report can be accessed from the
'Financial Reports and Circulars' section.
Attachment
* Current portfolio sector allocation
(https://ml-eu.globenewswire.com/Resource/Download/4f998f63-632e-4ffa-92a2-6f2e35c2285f)